A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability
Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhimin Lu(Shandong Sport University), Renda Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Sijin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yannan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Wang(Harbin Medical University), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoli Feng(Nanjing University of Chinese Medicine), Hong Cheng(Southern Medical University)
Cited by 84
Related Papers
Lipid metabolism and cancer
|The Journal of Experimental Medicine|2020|981
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
|Journal of Biological Chemistry|2007|871
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα
|Cell Metabolism|2022|402
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
|Nature Communications|2017|342